Renal transplantation in the elderly 583 assesses the patient and commissions IC from the above team if it is agreed that the patient has potential to benefit from further rehabilitation. Patients are also referred to the joint care manager by the primary health care team. Patients accepted for IC are then assessed by each discipline in the IC team and a care plan developed with delivery by the care assistants. Patients receive input for up to 6 weeks, according to need. 
Introduction
Life expectancy has increased in recent decades, so that those over 60 years represent an important segment of the general population. Thus, more than a quarter of the citizens in NorthWest Spain are older than this age [1] . Due to the characteristics of chronic renal disease, which increases with age, these demographic changes are clearly reflected in the population affected. Thus, this disease's incidence and prevalence have doubled in those over 60 in the United States during the last decade, representing more than 60% of the patients who initiated renal substitutive treatment in the year 2002 [2] . This percentage is similar to that of European countries [3] and there is even a significant proportion of those over 80, for whom renal replacement therapy is still an effective treatment [4] .
Traditionally, the patient's age was considered as a relative contraindication for renal transplantation. This is fundamentally due to the elevated comorbidity of the elderly undergoing renal replacement therapy and because the scarcity of donors encouraged the selection of those recipients who presumably could obtain more important benefits regarding survival. However, there is presently evidence that transplantation is the best treatment for patients with chronic kidney disease [5] , even those of older age [6, 7] . Thus, even though there is still some controversy, transplant teams accept older patients, transplantation becoming an increasingly more common therapeutic alternative in those over 60. In this way, they represent almost a quarter of the transplant recipients in some countries [8] .
The present study aimed to analyse the characteristics and compare the results of renal transplantations in patients over and under 60 years and the factors that influence graft survival to determine if there should be an age limit or, on the contrary, if transplantation should continue to increase in elderly patients.
Subjects and methods
We have analysed 672 renal grafts performed in Galicia (Spain), all from cadaveric donors, from January 1, 1996 to December 31, 2000, extending the follow-up period of the grafts and the patients until December 31, 2001. However, in an attempt to eliminate biases derived from their different characteristics, combined transplants (21), patients in paediatric age (2) and those who were lost to follow-up (2) were excluded. Thus, the final analysis was conducted on 647 grafts implanted in 621 patients. These were divided into two groups, according to age at the time of the transplantation: group A (<60 years) and group B (≥60 years). All patients were followed-up for a period of at least one year, though 354 patients were followed-up for three years and 109 patients for five years.
The data were collected in two hospitals with transplant teams (Juan Canalejo of A Coruña and Clínico Universitario of Santiago de Compostela). The clinical records in the hospital files were reviewed and, in the case of the patients who returned to dialysis after losing the graft, in the respective dialysis units. 
Statistical analysis
To verify the association between variables, the chi-squared, Student's t test and Mann-Whitney U test have been used, while the actuarial method, Kaplan-Meier curves, log-rank test and Cox proportional hazard models were used for the survival analysis. The method proposed by Grambsch and Therneau was used to assess hazard proportionality. Based on regression analysis coefficients, relative risks (RR) and 95% confidence intervals (CI) were calculated.
Results
A total of 621 patients, 484 (77.9%) of whom were under 60 years and 137 (22.1%) were 60 years or older, were included in the analysis. When the characteristics of both groups were compared (Table 1 ), significant differences were found with regards to retransplantation, which was more frequent in the younger subjects (P=0.003), to the baseline disease (there was a greater proportion of glomerulonephritis in the younger subjects (P<0.001) while diabetes mellitus was more frequent in the older subjects (P=0.008)), and to previous time in renal replacement therapy, which was greater (P=0.008) in those over 60 years. In addition, older patients received grafts from older donors, and while patients in group A received grafts that originated in the transplant hospital itself, those in group B came mostly from other extraction sites. Patient survival at one and five years was significantly greater (P<0.0001) in the younger group (96.3 and 86.4%) than in that of the older one (84.7 and 69.1%). The same occurred with graft survival ( Figure 1A ), which was 82.4 and 70.2% for group A patients and 72.5 and 55.7% for those of group B (P=0.0012). However, when graft survival was analysed excluding patients who died with a functioning graft ( Figure 1B) , no significant differences were found:
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Overall graft survival for all the patients was significantly greater (P<0.0001) when the donor was under 60 years than when the donor was older than this age (82.3 and 71.6% versus 71.5 and 45.0%, at one and five years, respectively). When the results of groups A and B were analysed based on the donor's age, older or younger than 60 years, we observed that when the group A patients were associated with young donors they had greater survival (84.2 and 73.9%, at 1 and 5 years) than those of group B, both when the latter were associated with old donors (73.2 and 45.8%; P=0.0006) or with young donors (72.1 and 60.2%; P=0.0036). However, if the group A patients are associated with old donors (70.1 and 44.3%) there are no significant differences with those of group B, both if the latter are associated with old donors (P=0.7631) or with young ones (P=0.211). The difference in group B patient survival when they are associated with young or old donors was also not statistically significant (P=0.4852).
In the multivariate analysis, including all the variables described in Table 1 in the model, the following were predictive factors for graft loss: recipient age over 60 years (relative risk [RR]=1.56; 95% confidence interval [CI] 1.09-2.25), presence of acute rejection episodes in the first year (RR=2.14; CI 1.52-3.01), donor age above 60 years (RR=1.63; CI 1.11-2.34) and non-heart beating donor (RR=3.42; CI 1.68-6.94).
Percentage of graft losses in group B was greater than in A (40.1 versus 26.3%; P=0.001). In regards to the causes of the loss, there were no significant differences in both groups, except in functioning kidneys lost due to the patient's death. These represented 47.4% of the losses in group B and 18.0% in group A (P<0.0001) ( Table 2) .
A total of 9.5% of the group A patients and 26.3% of those from group B (P<0.0001) died, however, there were no significant differences between the causes of death, the most frequent being infections (47.2% in group B and 30.4% in group A) and cardiovascular diseases (32.6% in group A and 27.8% in group B). When first year mortality was analysed, it was seen that the standard mortality index is 5.2 for all the recipient patients, it being 15.3 for group A and 4.2 for those of group B.
Discussion
Ageing of the general population entails an important increase in the age of patients with chronic kidney disease. More than 800 patients per one million inhabitants over 65 years begin renal substitutive treatment in Spain each year [9] . Consequently, the number of transplantations is increased in elderly subjects, so that almost a quarter of the transplant recipients exceed 60 years in some registries [8] , which agrees with our series, in which they represent 22%. However, transplantation in these patients continues to represent a controversy in this era of donor scarcity, since it is considered that survival after 65 years is similar for those with renal replacement therapy and for the transplant recipients [10] . The results of the many studies published are very different in regards to the influence of the recipient age on graft survival. Based on them, there are those that conclude, even after excluding losses due to the patient's death, that age is an important independent risk factor for development of chronic renal allograft failure [11] , while others do not find statistically significant differences [12, 13] .
In our study, age greater than 60 years represented an independent risk factor for graft loss. In these patients, survival was significantly lower, however, when patients who died with a functioning graft were excluded, survival was equal to that of the younger subjects, around 83 and 76%, at one and five years, respectively. In fact, coinciding with other series [13, 14] , the first cause of graft loss in the group over 60 years was the patient's death, which reached almost half of all the losses and was significantly greater than in the group of the younger subjects.
On the other hand, when graft survival was compared in both groups according to donor age, we verified that recipients under 60 years only had greater survival when they received a graft from a donor who was also young, while if the donor was over 60 years, no significant differences were observed. This suggests that the donor age is that which affects graft survival to the greatest degree. In fact, although there are controversies in this sense in the literature [15] [16] [17] , it represented a risk factor for graft lost in our series independently of the recipient age.
In any event, given that graft survival in the older patient did not significantly vary based on donor age, together with the unquestionable benefit of transplantation versus dialysis in regards to improving quality of life [18] , it is clear that elderly donors should be accepted, using them for patients of greater age, with less life expectancy, and who would not have any access to a transplantation otherwise [19] .
Logically, mortality was greater in the elderly recipient group and we consider it important to know what percentage of deaths can be attributed to the consequences of the transplantation and which are due to the same circumstances that cause death in the general population. In this sense, there are studies that indicate that mortality in the first year may be fourteen times greater than that of the population mean [20] . However, in our series, it is fifteen times greater for those transplant recipients under 60 years, while it is only four times greater in those over 60 years.
Finally, the results of our study show that recipient age alone cannot be a determining criterion to exclude elderly patients from the benefits of transplantation, since graft survival seems to be conditioned, to a larger degree, by the patient's comorbidity, on the basis of which he/she should be strictly selected, and by the donor's age. With respect to this issue, it is true that a debate could be made on the optimal use that should be given to the scarce number of organs available. However, to the position that younger patients should be given priority because of greater life expectancy we respond that the value of human life cannot be judged on the basis of age, and, thus, we believe that clinical criteria regarding comorbidity should be the only limitation for elderly patients to have access to renal transplantation.
Key points
• In the graft survival, excluding patients who died with a functioning graft, there were no significant differences among patients under 60 years and the older ones.
• Donor age is the factor which affects graft survival to the greatest degree, it represented a risk factor for graft loss independently of the recipient age.
• In regards to the causes of graft loss, there were no significant differences in both groups, except in functioning kidneys lost due to the patient's death.
• Recipient age alone cannot be a determining criterion to exclude elderly patients from the benefits of transplantation.
